Excision Arthroplasty With Interpositional Achilles Tendon Autograft: A Novel Approach to Talonavicular Joint Osteoarthritis Associated With Ankle Arthrodesis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10410810" target="_blank" >RIV/00216208:11130/20:10410810 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064203:_____/20:10410810
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=xuab7-XrnS" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=xuab7-XrnS</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1053/j.jfas.2017.12.018" target="_blank" >10.1053/j.jfas.2017.12.018</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Excision Arthroplasty With Interpositional Achilles Tendon Autograft: A Novel Approach to Talonavicular Joint Osteoarthritis Associated With Ankle Arthrodesis
Popis výsledku v původním jazyce
We have read the article entitled "Diabetic Driving Studies-Part 1: Brake Response Time in Diabetic Drivers With Lower Extremity Neuropathy" (JFAS 56:568-572, 2017) published in the May/June issue of your Journal with outmost interest because it has presented the data from a valuable and important study in an attempt to find an answer to a substantial question. The presented results bring an interesting finding that the study participants with a history of any ulceration, amputation, or Charcot neuroarthropathy (n = 136 trials [68.0%]) had a mean brake response time that was shorter (0.721 +- 0.139 seconds) and the range narrower (range 0.50 to 1.30 seconds) compared with participants without such a history (n = 64 trials [32.0%]) who had a brake response time of 0.833 +- 0.229 (range 0.51 to 1.68) seconds (p < .001). From the clinical viewpoint, we would expect the opposite, because these complications usually signal a greater degree of lower extremity neuropathy. In a search for an explanation, in addition to the comparatively small number of participants, a question was raised of possible hypoglycemia which could have occurred during or shortly before some of "the brake tests," thus would have accidentally influenced the subjects' reaction time. Furthermore, the study population consisted of type 2 diabetes mellitus patients-their treatment, however, was not described. The wide range of hemoglobin A1c values (5.5% to 10.1%) suggests that the study group might have also included patients treated with hypoglycemic drugs such as insulin or sulphonylurea derivatives. We would, therefore, like to ask Meyr et al to specify whether the blood glucose levels were checked, a history of recent hypoglycemia had been determined before "the brake test," and whether all the patients involved had been treated with nonhypoglycemic agents. We also, with great respect, suggest considering the question of hypoglycemia into the protocol of this interesting and important study, if its continuation is planned.
Název v anglickém jazyce
Excision Arthroplasty With Interpositional Achilles Tendon Autograft: A Novel Approach to Talonavicular Joint Osteoarthritis Associated With Ankle Arthrodesis
Popis výsledku anglicky
We have read the article entitled "Diabetic Driving Studies-Part 1: Brake Response Time in Diabetic Drivers With Lower Extremity Neuropathy" (JFAS 56:568-572, 2017) published in the May/June issue of your Journal with outmost interest because it has presented the data from a valuable and important study in an attempt to find an answer to a substantial question. The presented results bring an interesting finding that the study participants with a history of any ulceration, amputation, or Charcot neuroarthropathy (n = 136 trials [68.0%]) had a mean brake response time that was shorter (0.721 +- 0.139 seconds) and the range narrower (range 0.50 to 1.30 seconds) compared with participants without such a history (n = 64 trials [32.0%]) who had a brake response time of 0.833 +- 0.229 (range 0.51 to 1.68) seconds (p < .001). From the clinical viewpoint, we would expect the opposite, because these complications usually signal a greater degree of lower extremity neuropathy. In a search for an explanation, in addition to the comparatively small number of participants, a question was raised of possible hypoglycemia which could have occurred during or shortly before some of "the brake tests," thus would have accidentally influenced the subjects' reaction time. Furthermore, the study population consisted of type 2 diabetes mellitus patients-their treatment, however, was not described. The wide range of hemoglobin A1c values (5.5% to 10.1%) suggests that the study group might have also included patients treated with hypoglycemic drugs such as insulin or sulphonylurea derivatives. We would, therefore, like to ask Meyr et al to specify whether the blood glucose levels were checked, a history of recent hypoglycemia had been determined before "the brake test," and whether all the patients involved had been treated with nonhypoglycemic agents. We also, with great respect, suggest considering the question of hypoglycemia into the protocol of this interesting and important study, if its continuation is planned.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30202 - Endocrinology and metabolism (including diabetes, hormones)
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Foot and Ankle Surgery
ISSN
1067-2516
e-ISSN
—
Svazek periodika
59
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
1
Strana od-do
445
Kód UT WoS článku
000517090300040
EID výsledku v databázi Scopus
2-s2.0-85079609994